Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

NCT02839681 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

NIH

Sponsor class

Stopped Due to slow, insufficient accrual.

Conditions

Lung Neoplasms

Interventions

DRUG: Anetumab Ravtansine
DEVICE: Blood test

Sponsor

National Cancer Institute (NCI)